| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/10/2010 | CN101668740A Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester |
| 03/10/2010 | CN100593538C Method for preparing N-substituted acryloyl-2,5-pyrrole-dione compound |
| 03/09/2010 | US7675058 for immobilizing amine-containing materials to substrate |
| 03/09/2010 | US7674934 Stabilizers for use in NVP synthesis |
| 03/09/2010 | US7674916 Processing a dicarbonyl compound to form cyclic compound; reacting with an alkylating agent to form a derivative having an alkylated ring nitrogen |
| 03/09/2010 | US7674915 alkylating a 4-protected hydroxyl pyroglutamic acid derivative with an alkylating agent to prepare a 4-protected hydroxyl-4-alkylglutamic acid derivative, followed by the steps of hydrolysis and deprotection |
| 03/09/2010 | US7674820 Ion channel modulating activity I |
| 03/09/2010 | US7674819 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 03/09/2010 | US7674807 N-(1,1-dimethyl-2-methylsulfanyl-ethyl)-3-methanesulfonyloxy-phthalamic acid; 3-fluoro-N-(1-methyl-2-methylsulfanyl-ethyl)-phthalamic acid; effect against harmful insects without giving phytotoxicity on cultured plants |
| 03/09/2010 | US7674805 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 03/09/2010 | US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 03/09/2010 | US7674474 Pesticidal agents on the basis of 1-aryl-aminopyrrol |
| 03/09/2010 | CA2336702C Sulfonylaminocarboxylic acid n-arylamides as guanylate cyclase activators |
| 03/09/2010 | CA2306313C Dipeptide nitriles |
| 03/09/2010 | CA2140598C Prolineamide derivatives |
| 03/04/2010 | WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 03/04/2010 | WO2010024226A1 Prophylactic or therapeutic agent for bone/joint diseases comprising, as active ingredient, pyrrole derivative having ureide group, aminocarbonyl group and substituted phenyl group as substituents |
| 03/04/2010 | WO2010023725A1 Novel compound signamycin, method for production thereof, and use thereof |
| 03/04/2010 | WO2010023446A1 Novel potassium channel blockers |
| 03/04/2010 | WO2010023346A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses |
| 03/04/2010 | US20100056805 Process for producing 3,4-disubstituted pyrrolidine derivative and production intermediate thereof |
| 03/04/2010 | US20100056804 Compound containing carboxylate ester and N2S2 ligand bi-functional groups and manufacturing method thereof |
| 03/04/2010 | US20100056776 Method of preparing macromolecular contrast agents and uses thereof |
| 03/04/2010 | US20100056605 Oxidative degradation products of atorvastatin calcium |
| 03/04/2010 | US20100056602 Substituted Pyrrole Derivatives And Their Use As HMG-CO Inhibitors |
| 03/04/2010 | US20100056598 Cis-alkoxy-substituted spirocyclic 1h-pyrrolidine-2,4-dione derivatives serving as pesticides |
| 03/04/2010 | US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient |
| 03/04/2010 | US20100056497 Amide derivative |
| 03/04/2010 | US20100056495 Dimeric iap inhibitors |
| 03/04/2010 | US20100055582 Colored curable composition, color filter and method of producing the same, and dipyrromethene metal complex compound and tautomer thereof |
| 03/04/2010 | CA2735419A1 Compound signamycin, method for producing the same, and use of the same |
| 03/04/2010 | CA2733648A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 03/03/2010 | EP1753719B1 Substituted pyrrolidine-2-ones |
| 03/03/2010 | EP1732886B1 Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
| 03/03/2010 | EP1698622B1 Treatment for severe aphasia in chronic-stage cerebrovascular disorder |
| 03/03/2010 | EP1542969B1 Pyrrolidone derivatives as maob inhibitors |
| 03/03/2010 | EP1487790B1 Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization |
| 03/03/2010 | CN101663271A Maleimide containing ester and sulfide functionalities |
| 03/02/2010 | US7671216 Avoiding selective hydrolysis of methyl ester in the presence of tert-butyl ester by using a mineral aid simultaneously to induce acid-catalyzed cleavageof ketal and the hydroxy protecting group; avoid the use of air- and moisture-sensitive reagents; cost efficiency; simplification |
| 03/02/2010 | US7671215 Process for the preparation of compounds having an ace inhibitory action |
| 03/02/2010 | US7671076 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 03/02/2010 | US7671073 4-{(1S,2S)-2-Amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl}-1-[1,2,4]triazolo[1,5-a]pyridin-6-ylcyclohexanol, bis(trifluoroacetic acid); non-insulin dependent (Type 2) diabetes, hyperglycemia; dipeptidyl peptidase-IV inhibitors |
| 03/02/2010 | US7671032 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 02/25/2010 | WO2010022033A2 Therapeutic substituted pyrroles |
| 02/25/2010 | WO2010021878A1 Cold menthol receptor antagonists |
| 02/25/2010 | WO2010020055A1 Small molecule inhibitors of n-terminus activation of the androgen receptor |
| 02/25/2010 | WO2009152356A3 Compounds and compositions useful for the treatment of malaria |
| 02/25/2010 | US20100048893 Substituted arylalkanoic acid derivatives and use thereof |
| 02/25/2010 | US20100048665 3-aminopyrrolidone derivatives |
| 02/25/2010 | US20100048664 Therapeutic substituted pyrroles |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | US20100048589 Cold Menthol Receptor Antagonists |
| 02/25/2010 | US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/25/2010 | US20100048549 Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 |
| 02/25/2010 | US20100048545 Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity |
| 02/25/2010 | US20100048531 GlyT1 RECEPTOR ANTAGONISTS |
| 02/25/2010 | US20100048483 Polymeric benzyl carbonate-derivatives |
| 02/25/2010 | US20100047603 Treatment of wood |
| 02/25/2010 | CA2730478A1 Prodrugs of methyl hydrogen fumarate |
| 02/25/2010 | CA2728103A1 Small molecule inhibitors of n-terminus activation of the androgen receptor |
| 02/24/2010 | EP2155672A1 Prolinamide derivatives as nk3 antagonists |
| 02/24/2010 | EP2155671A2 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 02/24/2010 | EP2155670A1 Anti -inflammatory substituted cyclobutenedione compounds |
| 02/24/2010 | EP2155669A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 02/24/2010 | EP2155668A2 Crystalline forms of (r)-1-{2-ý4'- (3-methoxy-propane-1- sulfonyl)-biphenyl-4-yl¨-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 02/24/2010 | EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |
| 02/24/2010 | EP1658066B9 Adamantylglycine- based inhibitors of dipeptidyl peptidase iv for the treatment of diabetes |
| 02/24/2010 | CN101657420A Process for preparing porphyrin derivatives, such as protoporphyrin (IX) and synthesis intermediate |
| 02/24/2010 | CN101657419A Novel crystal forms of pyrrolylheptanoic acid derivatives |
| 02/24/2010 | CN101657418A Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists |
| 02/24/2010 | CN101654425A L-proline trifluoromethanesulfonic acid ammonium salt and application thereof |
| 02/24/2010 | CN100591676C 2- and 2,5-substituted phenylketo-enols |
| 02/23/2010 | US7667049 Chemical intermediates for the production of novel antibiotics 10-(3-cyclopropylaminomethyl-4-fluoropyrrolidinyl)pyridobenzoxazine carboxylic acid derivatives which are effective against drug resistant bacteria |
| 02/23/2010 | US7667048 Green and orange fluorescent labels and their uses |
| 02/23/2010 | US7667047 Black for electrophotographic toners and inkjet inks, look black but, unlike carbon black, do not absorb infrared light; crystal form of 1-(3,5-dimethylpyrrol-2-yl)-3-(3,5-dimethylpyrrolium-2-ylidene)-cyclobuten-2-one-4-olate |
| 02/23/2010 | US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 02/23/2010 | US7667044 treating nervous system diorders such as Alzheimer's disease, Down Syndrome, Parkinson disease and Huntington chorea by administering inhibitors of prolyl endopeptidases |
| 02/23/2010 | US7666885 Enzyme inhibitors |
| 02/23/2010 | US7666869 Nitrogen-containing 5-membered ring compound |
| 02/23/2010 | US7666866 Antithrombotic diamides |
| 02/23/2010 | CA2433685C Primary intermediates for oxidative coloration of hair |
| 02/18/2010 | WO2010019832A2 Amide-extended crosslinking compounds and methods for use thereof |
| 02/18/2010 | WO2010019435A2 Solid states of atorvastatin potassium |
| 02/18/2010 | WO2010018926A2 Method for preparing n-substituted maleimides |
| 02/18/2010 | WO2010018112A2 Monoaryl aminotetralines |
| 02/18/2010 | WO2009084773A3 Preparation process useful in synthesis of atorvastatin |
| 02/18/2010 | US20100041867 Reversible pegylated drugs |
| 02/18/2010 | US20100041845 Hetero-functional compounds and methods for use thereof |
| 02/18/2010 | US20100041731 Solid states of atorvastatin potassium |
| 02/18/2010 | US20100041674 Hcv protease inhibitors and uses thereof |
| 02/18/2010 | US20100040569 Photo-labile pro-fragrance conjugates |
| 02/18/2010 | US20100040547 Dyes and precursors and conjugates thereof |
| 02/18/2010 | US20100038578 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device |
| 02/18/2010 | CA2732210A1 Monoaryl aminotetralines |
| 02/17/2010 | EP2152669A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof |
| 02/17/2010 | EP2152262A2 New heterocyclic derivatives useful for the treatment of cns disorders |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/16/2010 | US7662977 Such as 2-cationic amino-4-oxo-chromene derivatives; water solubility, pharmacokinetics; reduced side effects; anticancer agents |
| 02/16/2010 | US7662908 preparing activated polyethylene glycols is disclosed. In some embodiments, the process includes reacting a molten polyethylene glycol with an activator. , the process includes reacting a polyethylene glycol with an activator in the absence of a solvent. The process may be carried out in an inert gas |
| 02/16/2010 | US7662891 a cyclohexyl amine salt of N-substituted succinimide thio group-containing carboxylic acid, used as vulcanization agent or promoters for diene-based or halogenated rubbers |